By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has inked technology access agreements with the National Cancer Institute and National Human Genome Research Institute, under which researchers at the two institutes will use Horizon's rAAV gene editing technology, called Genesis, to engineer human isogenic disease models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.